Curcumin
Alzheimer's disease (AD) is diagnosed (by autopsy) by the presences of what are called neurofibrillary tangles, senile plaques and loss of neurons. It is clear that oxidative stress and inflammation have an important role in AD. Curcumin is a compound with broad spectrum antioxidant, anti-inflamatory and anti-fibrilogenic activities. One recent study suggests that the natural product curcumin represents a "hopeful approach for delaying or preventing the progression of AD". Other studies have shown that curcumin prevents neural damage and reduces both oxidative stress and plaque accumulation. Curcumin prevents the formation of new deposits, clearing existing deposits, and reducing the size of remaining deposits. This data confirms that not only can curcumin suppress new plaques but also remove previous deposited ones. Data also shows that well known supplements, such as vitamin E and Ginkgo Biloba extract, have no effect on these plaques. Curcumin represents the "new frontier" of health supplements in disease prevention and treatment.
These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, cure or prevent any disease.
References
